Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (26)
E. G. Poltavskaya, V. V. Tiguntsev, A. S. Boiko, E. G. Kornetova, S. A. Ivanova & O. Yu. Fedorenko. (2023) Study of Associations of the GRM8 Gene with Antipsychoticinduced Hyperprolactinemia. Personalized Psychiatry and Neurology 3:1, pages 42-47.
Crossref
Crossref
Diana Z. Paderina, Anastasiia S. Boiko, Ivan V. Pozhidaev, Irina A. Mednova, Anastasia A. Goncharova, Anna V. Bocharova, Olga Yu. Fedorenko, Elena G. Kornetova, Arkadiy V. Semke, Nikolay A. Bokhan, Anton J. M. Loonen & Svetlana A. Ivanova. (2022) The Gender-Specific Association of DRD2 Polymorphism with Metabolic Syndrome in Patients with Schizophrenia. Genes 13:8, pages 1312.
Crossref
Crossref
Olga Yu. Fedorenko, Diana Z. Paderina, Elena G. Kornetova, Evgeniya G. Poltavskaya, Ivan V. Pozhidaev, Anastasiia A. Goncharova, Maxim B. Freidin, Anna V. Bocharova, Nikolay A. Bokhan, Anton J. M. Loonen & Svetlana A. Ivanova. (2022) Genes of the Glutamatergic System and Tardive Dyskinesia in Patients with Schizophrenia. Diagnostics 12:7, pages 1521.
Crossref
Crossref
Rosa Maria Paragliola, Nadine Binart & Roberto Salvatori. 2022. The Pituitary. The Pituitary
131
172
.
Y.W. Francis Lam. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
277
301
.
Yaowaluck Hongkaew, Andrea Gaedigk, Bob Wilffert, Roger Gaedigk, Wiranpat Kittitharaphan, Nattawat Ngamsamut, Penkhae Limsila, Apichaya Puangpetch, Rattanaporn Sukprasong & Chonlaphat Sukasem. (2021) Pharmacogenomics Factors Influencing the Effect of Risperidone on Prolactin Levels in Thai Pediatric Patients With Autism Spectrum Disorder. Frontiers in Pharmacology 12.
Crossref
Crossref
Chuanjun Zhuo, Yong Xu, Haibo Wang, Tao Fang, Jiayue Chen, Chunhua Zhou, Qianchen Li, Jie Liu, Shuli Xu, Cong Yao, Weiliang Yang, Anqu Yang, Bo Li, Yuhui Chen, Hongjun Tian & Chongguang Lin. (2021) Safety and Efficacy of High-Dose Vitamin B6 as an Adjunctive Treatment for Antipsychotic-Induced Hyperprolactinemia in Male Patients With Treatment-Resistant Schizophrenia. Frontiers in Psychiatry 12.
Crossref
Crossref
Diana Z. Paderina, Anastasiia S. Boiko, Ivan V. Pozhidaev, Anna V. Bocharova, Irina A. Mednova, Olga Yu. Fedorenko, Elena G. Kornetova, Anton J.M. Loonen, Arkadiy V. Semke, Nikolay A. Bokhan & Svetlana A. Ivanova. (2021) Genetic Polymorphisms of 5-HT Receptors and Antipsychotic-Induced Metabolic Dysfunction in Patients with Schizophrenia. Journal of Personalized Medicine 11:3, pages 181.
Crossref
Crossref
Anastasia Levchenko, Alexander Kanapin, Anastasia Samsonova, Olga Yu. Fedorenko, Elena G. Kornetova, Timur Nurgaliev, Galina E. Mazo, Arkadiy V. Semke, Alexander O. Kibitov, Nikolay A. Bokhan, Raul R. Gainetdinov & Svetlana A. Ivanova. (2021) A genome-wide association study identifies a gene network associated with paranoid schizophrenia and antipsychotics-induced tardive dyskinesia. Progress in Neuro-Psychopharmacology and Biological Psychiatry 105, pages 110134.
Crossref
Crossref
S.A. Ivanova, D.Z. Paderina, A.S. Boiko, I.V. Pozhidaev, E.G. Kornetova, B. Wilffert & A.J.M. Loonen. (2020) P.583 Polymorphisms in BDNF, AKT1, GSK3B genes: possible association with antipsychotic-induced hyperprolactinemia in schizophrenia patients. European Neuropsychopharmacology 40, pages S331-S332.
Crossref
Crossref
V. Tiguntsev, E. Kornetova Georgievna & A. Kornetov Nikolaevich. (2020) P.514 Contribution of polymorphic variants of MAO genes into prolactin levels in patients with schizophrenia under risperidone therapy. European Neuropsychopharmacology 40, pages S290-S291.
Crossref
Crossref
Lisanne M. Geers, Ivan V. Pozhidaev, Svetlana A. Ivanova, Maxim B. Freidin, Amand F. Schmidt, Dan Cohen, Anastasiia S. Boiko, Diana Z. Paderina, Olga Yu Fedorenko, Arkadiy V. Semke, Nikolay A. Bokhan, Bob Wilffert, Jos G.W. Kosterink, Daan J. Touw & Anton J.M. Loonen. (2020) Association between 8 P‐glycoprotein (MDR1/ABCB1) gene polymorphisms and antipsychotic drug‐induced hyperprolactinaemia. British Journal of Clinical Pharmacology 86:9, pages 1827-1835.
Crossref
Crossref
Svetlana Ivanova, Diana Paderina, Anastasiia Boiko, Olga Fedorenko, Ivan Pozhidaev, Vladimir Tigunsev, Elena Kornetova, Nikolay Bokhan, Bob Wilffert & Anton Loonen. (2020) COMT gene polymorphism and antipsychotic- induced hyperprolactinemia in schizophrenia patients. COMT gene polymorphism and antipsychotic- induced hyperprolactinemia in schizophrenia patients.
Olga Yu. Fedorenko, Diana Z. Paderina, Anton J. M. Loonen, Ivan V. Pozhidaev, Anastasiia S. Boiko, Elena G. Kornetova, Nikolay A. Bokhan, Bob Wilffert & Svetlana A. Ivanova. (2020)
Association of
ANKK1
polymorphism with antipsychotic‐induced hyperprolactinemia
. Human Psychopharmacology: Clinical and Experimental 35:4.
Crossref
Crossref
Dora Koller & Francisco Abad-Santos. (2020) The pharmacogenetics of aripiprazole-induced hyperprolactinemia: what do we know?. Pharmacogenomics 21:9, pages 571-574.
Crossref
Crossref
Dora Koller, Carmen Belmonte, Miriam Saiz‐Rodríguez, Pablo Zubiaur, Manuel Román, Dolores Ochoa & Francisco Abad‐Santos. (2019) Effects of aripiprazole on circadian prolactin secretion related to pharmacogenetics in healthy volunteers. Basic & Clinical Pharmacology & Toxicology 126:3, pages 236-246.
Crossref
Crossref
Karin Hrovatin, Tanja Kunej & Vita Dolžan. (2019) Genetic variability of serotonin pathway associated with schizophrenia onset, progression, and treatment. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 183:2, pages 113-127.
Crossref
Crossref
Taichi Ochi, Natalya M. Vyalova, Innokentiy S. Losenkov, Diana Z. Paderina, Ivan V. Pozhidaev, Anton J. M. Loonen, German G. Simutkin, Nikolay A. Bokhan, Svetlana A. Ivanova & Bob Wilffert. (2019) Limited Associations Between 5-HT Receptor Gene Polymorphisms and Treatment Response in Antidepressant Treatment-Free Patients With Depression. Frontiers in Pharmacology 10.
Crossref
Crossref
S. A. Ivanova. (2019) New approaches to pharmacogenetics of drug-induced hyperprolactinemia in patients with schizophrenia. V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY:4-1, pages 21-23.
Crossref
Crossref
D. Osmanova, I. Pozhidaev, A. Loonen & S. Ivanova. (2019) P.557 Polymorphisms of serotonin receptor and tryptophan hydroxylase genes and risperidone-induced hyperprolactinemia in patients with schizophrenia. European Neuropsychopharmacology 29, pages S391-S392.
Crossref
Crossref
O. Fedorenko, S. Ivanova & A. Loonen. (2019) P.085 Association of ankyrin repeat and kinase domain containing 1 gene polymorphism with schizophrenia and antipsychotic-induced hyperprolactinemia. European Neuropsychopharmacology 29, pages S77-S78.
Crossref
Crossref
Olga Yu. Fedorenko, Vera E. Golimbet, Svetlana А. Ivanova, Аnastasia Levchenko, Raul R. Gainetdinov, Arkady V. Semke, German G. Simutkin, Аnna E. Gareeva, Аndrey S. Glotov, Anna Gryaznova, Ivan Y. Iourov, Evgeny M. Krupitsky, Igor N. Lebedev, Galina E. Mazo, Vasily G. Kaleda, Lilia I. Abramova, Igor V. Oleichik, Yulia A. Nasykhova, Regina F. Nasyrova, Anton E. Nikolishin, Evgeny D. Kasyanov, Grigory V. Rukavishnikov, Ilgiz F. Timerbulatov, Vadim M. Brodyansky, Svetlana G. Vorsanova, Yury B. Yurov, Tatyana V. Zhilyaeva, Anzhelika V. Sergeeva, Elena A. Blokhina, Edwin E. Zvartau, Anna S. Blagonravova, Lyubomir I. Aftanas, Nikolay А. Bokhan, Zurab I. Kekelidze, Tatyana V. Klimenko, Irina P. Anokhina, Elza K. Khusnutdinova, Tatyana P. Klyushnik, Nikolay G. Neznanov, Vadim A. Stepanov, Thomas G. Schulze & Аleksandr О. Kibitov. (2019) Opening up new horizons for psychiatric genetics in the Russian Federation: moving toward a national consortium. Molecular Psychiatry 24:8, pages 1099-1111.
Crossref
Crossref
Diana Z. Osmanova, Maxim B. Freidin, Olga Yu. Fedorenko, Ivan V. Pozhidaev, Anastasiia S. Boiko, Natalia M. Vyalova, Vladimir V. Tiguntsev, Elena G. Kornetova, Anton J. M. Loonen, Arkadiy V. Semke, Bob Wilffert, Nikolay A. Bokhan & Svetlana A. Ivanova. (2019) A pharmacogenetic study of patients with schizophrenia from West Siberia gets insight into dopaminergic mechanisms of antipsychotic-induced hyperprolactinemia. BMC Medical Genetics 20:S1.
Crossref
Crossref
Yaowaluck Hongkaew, Sadeep Medhasi, Ekawat Pasomsub, Nattawat Ngamsamut, Apichaya Puangpetch, Natchaya Vanwong, Monpat Chamnanphon, Penkhae Limsila, Chuthamanee Suthisisang, Bob Wilffert & Chonlaphat Sukasem. (2018) UGT1A1 polymorphisms associated with prolactin response in risperidone-treated children and adolescents with autism spectrum disorder. The Pharmacogenomics Journal 18:6, pages 740-748.
Crossref
Crossref
Svetlana A. Ivanova, Melloney J. Dröge, Haukeline H. Volders, Bernard J. van Vliet, Nikolay A. Bokhan, Fokko J. Bosker & Anton J.M. Loonen. (2018) Remaining Need for In Vitro Test to Elucidate 5-Hydroxytryptamine 2C Receptor Functioning. Journal of Clinical Psychopharmacology 38:4, pages 410-411.
Crossref
Crossref
Patricia Gassó, Sergi Mas, Miquel Bioque, Bibiana Cabrera, Antonio Lobo, Ana González-Pinto, Covadonga M Díaz-Caneja, Iluminada Corripio, Eduard Vieta, Josefina Castro-Fornieles, Salvador Sarró, Anna Mané, Julio Sanjuan, Adrián Llerena, Amalia Lafuente, Jerónimo Saiz-Ruiz & Miguel Bernardo. (2018)
Impact of
NTRK2, DRD2
and
ACE
polymorphisms on prolactin levels in antipsychotic-treated patients with first-episode psychosis
. Journal of Psychopharmacology 32:6, pages 702-710.
Crossref
Crossref